[en] To test the hypothesis that delayed onset muscular soreness (DOMS) following intense eccentric muscle contraction could be due to increased production of prostaglandin E(2) (PGE(2)), ten healthy male subjects were studied. Using a double-blind randomized crossover design, each subject performed two isokinetic tests separated by a period of at least 6 weeks: once with placebo, and once with piroxicam (Feldene((R))). They were given one capsule containing either placebo or piroxicam (20 mg) per day for 6 days with initial doses given starting 3 days prior to isokinetic testing. Exercise consisted of eight stages of five maximal contractions of the knee extensor and flexor muscle groups of both legs separated by 1 min rest phases, on a Kin Trex device at 60( degrees )/s angular velocity. The subjective presence and intensity of DOMS were evaluated using a visual analogue scale immediately after, and 24 and 48 h after each test. The mean plasma concentration of PGE(2) measured at rest and after exercise was significantly lower in the group treated with piroxicam (p < 0.05). However, statistical analysis (two-way ANOVA test) revealed that exercise did not cause any significant change of mean plasma PGE(2) over time in either of the two groups. Eccentric work was followed by severe muscle pain in extensor and flexor muscle groups. Maximal soreness was noted 48 h postexercise. Serum creatine kinase activity and the serum concentration of myoglobin increased significantly, and reached peak values 48 h after exercise in both experimental conditions (p < 0.001). By paired t-test, it appeared that there were no significant differences in the serum levels of these two markers of muscle damage between the two groups at any time point. We conclude that: (1) oral administration of piroxicam fails to reduce muscle damage and DOMS caused by strenuous eccentric exercise; and (2) the hypothetical role of increased PGE(2) production in eccentric exercise-induced muscle damage, DOMS, and reduced isokinetic performance is not substantiated by the present results.
Disciplines :
Human health sciences: Multidisciplinary, general & others Anesthesia & intensive care
Author, co-author :
Croisier, Jean-Louis ; Université de Liège - ULiège > Département des sciences de la motricité > Kinésithérapie générale et réadaptation
Camus, G.
Monfils, T.
Deby, Ginette ; Université de Liège - ULiège > Centre de l'oxygène : Recherche et développement (C.O.R.D.)
Fafchamps, M.
Venneman, Ingrid ; Centre Hospitalier Universitaire de Liège - CHU > Anesthésie et réanimation
Crielaard, Jean-Michel ; Université de Liège - ULiège > Département des sciences de la motricité > Evaluation et entraînement des aptitudes physiques - Médecine physique et réadaptation fonctionnelle
Round JM, Jones DA, Cambridge G. Cellular infiltrates in human skeletal muscle: exercise induced damage as a model for inflammatory muscle disease? J Neurol Sci 1987; 82: 1–11.
Young EW, Sparks HV. Prostaglandin E release from dog skeletal muscle during restricted flow exercise. Am J Physiol 1979; 236: H596–H599.
Symons JD, Theodossy SJ, Longhurst JC, Stebbins CL. Intramuscular accumulation of prostaglandins during static contraction of the cat triceps surae. J Appl Physiol 1991; 71: 1837–1842.
Camus G, Deby-Dupont G, Duchateau J, Deby C, Pincemail J, Lamy M. Are similar inflammatory factors involved in strenuous exercise and sepsis? Intensive Care Med 1994; 20: 602–610.
Croisier J-L, Camus G, Deby-Dupont G, Bertrand F, Crielaard J-M, Lhermerout C, Lamy M. Muscle damage and delayed muscular soreness induced by eccentric isokinetic exercise. Pflügers Archiv 1995; 429: R11.
Friden J, Skafianos PN, Hargens AR. Delayed muscle soreness and intramuscular fluid pressure: comparison between eccentric and concentric load. J Appl Physiol 1986; 61: 2175–2179.
Hasson SM, Daniels JC, Divine JG, Niebuhr BR, Richmond S, Stein PG, Williams JH. Effect of ibuprofen use on muscle soreness, damage, and performance: a preliminary investigation. Med Sci Sports Exerc 1993; 25: 9–17.
Herbaczynska-Cedro K, Staszewska-Barczak J, Janczewska H. Muscular work and the release of prostaglandin-like substances. Cardiovasc Res 1976; 10: 413–420.
Jones DA, Newham DJ, Round JM, Tolfree SEJ. Experimental human muscle damage morphological changes in relation to other indices of damage. J Physiol Lond 1986; 375: 435–448.
Kuipers H, Keizer HA, Verstappen FTJ, Costill DL. The influence of a prostaglandin inhibiting drug on muscle soreness after eccentric work. Int J Sports Med 1985; 6: 336–339.
Nowak J, Wennmalm A. Effect of exercise on human arterial and regional venous plasma concentration of prostaglandin E. Prostaglandin Med 1978; 1: 489–497.
Headley SA, Newham DJ, Jones DA. The effects prednisolone on exercise induced muscle pain and damage. Clin Sci 1986; 70: 85P.
Camus G, Pincemail J, Deby-Dupont G, Deby C, Juchmès-Ferir A, Lamy M. Effects of methylprednisolone on exercise-induced increases of polymorphonuclear elastase and myeloperoxidase in man. Preliminary results. Mediators of Inflammation 1993; 2: 323–326.
Newham DJ, Jones DA, Edwards RHT. Plasma creatine kinase changes after eccentric and concentric contractions. Muscle Nerve 1986; 9: 59–63.
Donnelly AE, McCormick K, Maughan RJ, Whiting PH, Clarkson PM. Effects of non-steroidal anti-inflammatory drug on delayed onset muscle soreness and indices of damage. Br J Sports Med 1988; 22: 35–38.
Salminen A, Kihlström M. Protective effect of indomethacin against exercise-induced injuries in mouse skeletal muscle fibres. Int J Sports Med 1987; 8: 46–49.
Smith LL. Acute inflammation: the underlying mechanism in delayed onset muscle soreness? Med Sci Sports Exerc 1991; 23: 542–551.
Francis KT, Hoobler T. Effects of aspirin on delayed muscle soreness. J Sports Med 1987; 27: 333-337.
Friden J, Sjostrom M, Ekblom B. Myofibrillar damage after intense eccentric exercise in man. Int J Sports Med 1983; 4: 170–176.